MedPath

Effectiveness of a Treatment Protocol for Lower Urinary Tract Symptoms in General Practice

Not Applicable
Completed
Conditions
Lower Urinary Tract Symptoms
Benign Prostatic Hyperplasia
Interventions
Procedure: current usual care
Procedure: treatment protocol with clear indications for therapy
Registration Number
NCT00111592
Lead Sponsor
Maastricht University Medical Center
Brief Summary

Ageing and the availability of medication has led to an increase of elderly male patients being treated for lower urinary tract symptoms (LUTS), or voiding problems ("prostate problems"). However, guidelines are vague as to which patients should and which should not be treated, and how.

Although several treatment modalities have proven efficacy in selected populations, it is unclear how effective these treatments are in daily practice.

This study investigates the hypothesis that a treatment protocol in which clear indications are formulated for all treatment modalities is more effective, as compared to current usual primary care, in reducing both symptoms as related to the quality of voiding in elderly males.

Detailed Description

Guidelines fail to provide specific diagnostic criteria and clear indications for therapy in elderly male patients with lower urinary tract symptoms. Consequently, the group of patients diagnosed with LUTS in primary care is very heterogeneous, and daily care varies widely.

Consequently, efficacy trials of alpha-blockers, 5-alpha-reductase inhibitors and surgery performed in selected, well defined homogeneous populations cannot easily be generalised to the heterogeneous primary care situation.

A practical randomised trial enrolling patients on the basis of symptoms have the advantage of being of immediate practical value.

We compare a treatment protocol with clear indications for therapy with current usual care in a population selected on symptoms rather than well defined diseases or definite test results.

Two hundred eight subjects were randomised into intervention (N=104) and control (N=104) conditions.

After two years of follow-up, IPSS scores, bother scores, maximum urinary flow rates and the incidence of acute urinary retention and urinary tract infections have been compared.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
208
Inclusion Criteria
  • International Prostate Symptom Score > 7
  • Age > 55 years
Exclusion Criteria
  • Heart failure
  • Diabetes type I
  • Psychiatric disorder/cognitive dysfunction
  • History of prostate surgery
  • Active treatment for lower urinary tract symptoms

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1current usual carecurrent usual care
2treatment protocol with clear indications for therapytreatment protocol with clear indications for therapy
Primary Outcome Measures
NameTimeMethod
Maximum urinary flow rate (Qmax)
Degree of lower urinary tract symptoms (International Prostate Symptom Score [IPSS])
Secondary Outcome Measures
NameTimeMethod
incidence of urinary tract infections
incidence of acute urinary retention
Bother due to lower urinary tract symptoms (Danish-Prostatic Symptom Score [Dan-PSS])

Trial Locations

Locations (1)

University of Maastricht, Department of General Practice

🇳🇱

Maastricht, Limburg, Netherlands

© Copyright 2025. All Rights Reserved by MedPath